Practical Considerations for GCP Audits in a Risk-based Environment Session Chair : Michael R. Hamrell |
Mon, June 24 11:00AM CME, IACET, RN
|
Vendor Management Using Quality by Design and Risk Management Strategies Session Chair : Sherri A. Hubby |
Mon, June 24 11:00AM IACET
|
Chemistry, Manufacturing and Controls (CMC) Regulatory Landscape in Emerging Markets Session Chair : Thirunellai G Venkateshwaran |
Mon, June 24 11:00AM CME, IACET, RN
|
Evaluation and Selection of the Optimal Endpoints for Clinical Studies Session Chair : Freda W. Cooner |
Mon, June 24 11:00AM ACPE, CME, IACET, RN
|
Electronic Health Records (EHRs) in Signal Detection and Evaluation Session Chair : Preciosa M. Coloma |
Mon, June 24 11:00AM ACPE, CME, IACET, RN
|
Narrative Medicine and Pharmacovigilance Session Chair : Michael A. Ibara |
Mon, June 24 11:00AM CME, IACET, RN
|
Is There a Disagreement? We Can Help - Dispute Resolution between Industry and US/EU Regulators Session Chair : Virginia L. Behr |
Mon, June 24 11:00AM CME, IACET, RN
|
Pediatric Drug Development: A New Paradigm Under FDASIA Session Chair : Rosemary M. Addy |
Mon, June 24 11:00AM ACPE, CME, IACET, RN
|
Next Generation Medical Information Call Center Session Chair : Charles M. Kalfaian |
Mon, June 24 11:00AM
|
Cooperation Among Regulators: Impact on Stakeholders Session Chair : Marie Allison Dray,Murray M. Lumpkin |
Mon, June 24 2:30PM ACPE, CME, IACET, RN
|
Quality Risk Management: An Old Hat? Session Chair : Beat E. Widler |
Mon, June 24 2:30PM CME, IACET, RN
|
Translational Aspects from Preclinical Animal Toxicology Studies to Early Human Health Risk Assessment: Needs and Limitations Session Chair : Celine Adessi |
Mon, June 24 2:30PM ACPE, CME, IACET, RN
|
Using Epidemiologic Methods to Advance Comparative Effectiveness Research Session Chair : Nancy A Dreyer |
Mon, June 24 2:30PM ACPE, CME, IACET, RN
|
Update on Submission and GMP Expectations for Part 3 Combination Products Session Chair : Michael Folkendt |
Mon, June 24 2:30PM CME, IACET, RN
|
Key Multiplicity Issues in Clinical Trials Session Chair : Alex Dmitrienko |
Mon, June 24 2:30PM CME, IACET, RN
|
CDISC SHARE: A Promising Approach to Therapeutic Area Standards Development Session Chair : Julie Evans |
Mon, June 24 2:30PM ACPE, CME, IACET, RN
|
That Awkward Stage: Transition from Paper Trial Master File to eTMF Session Chair : Denise Derenzo Lacey |
Mon, June 24 2:30PM IACET
|
The New Standards for the Identification of Medicinal Products and Individual Case Safety Reporting Applied in Pharmacovigilance Session Chair : Sabine Brosch |
Mon, June 24 2:30PM CME, IACET, RN
|
Characterizing Drug Shortages and Their Causes: Anticipating Future Trends Session Chair : Kenneth A. Getz |
Mon, June 24 2:30PM ACPE, CME, IACET, RN
|
Navigating the Regulatory Pathway for Advanced Therapy Medicinal Products (ATMPs) and Combined ATMPs Session Chair : Mark J. Hope |
Mon, June 24 2:30PM CME, IACET, RN
|
Is This Trial Worth It? A Panel Discussion for Sites and Project Managers Session Chair : Rodney William Butt |
Tue, June 25 8:00AM CME, IACET, PMI, RN
|
GCP and Inspection Readiness Session Chair : Marta Haley Fields |
Tue, June 25 8:00AM CME, IACET, RN
|
The Financial, Resource and Planning Challenges of Incorporation of Mandatory Language into Protocols Session Chair : Anne B. Cropp |
Tue, June 25 8:00AM CME, IACET, RN
|
The Thorough QT Study: Isn’t There a Better Way to Do This? Session Chair : Jay W Mason |
Tue, June 25 8:00AM ACPE, CME, IACET, RN
|
Postmarket Surveillance Issues for Medical Devices Session Chair : Kirsten H. Paulson |
Tue, June 25 8:00AM ACPE, CME, IACET, RN
|
Payer Collaborations with Pharma: Real-world Evidence to Improve Patient Outcomes and Influence the Pipeline Session Chair : Christopher M. Marrone |
Tue, June 25 8:00AM ACPE, CME, IACET, RN
|
Biomarkers for Drug Development: How Are We Dealing with the Challenges? Session Chair : Sue-Jane Wang |
Tue, June 25 8:00AM CME, IACET, RN
|
Developing and Embracing a Culture of Quality in the Pharmaceutical Industry Session Chair : Mary Oates |
Tue, June 25 8:00AM ACPE, CME, IACET, RN
|
Data from Everyone: Using Smartphones and the Internet to Connect with Subjects Session Chair : Anne M. Zielinski |
Tue, June 25 8:00AM CME, IACET, RN
|
Social Media, Mobile Applications and Patient Support Programs: Challenges and Solutions for Handling Drug Safety Information Session Chair : Arpad Simon |
Tue, June 25 8:00AM ACPE, CME, IACET, RN
|
A Regulatory Perspective of Biosimilars in Emerging Markets Session Chair : Linda F. Bowen |
Tue, June 25 8:00AM CME, IACET, RN
|
Research Advances for Rare Diseases and Orphan Products Session Chair : Peter L. Saltonstall |
Tue, June 25 8:00AM ACPE, CME, IACET, RN
|
Moving to a Standards-based, Agile Clinical Development Lifecycle Session Chair : Julie Smiley |
Tue, June 25 8:00AM
|
Optimizing Trial Feasibility by Leveraging Electronic Health Record (EHR) Data and Engaging Investigators and Patient Advocacy Groups Session Chair : Lisa Palladino Kim |
Tue, June 25 10:15AM ACPE, CME, IACET, RN
|
Effective Diverse Team Collaboration and Management for Drug Development: Key Commonalities and Differences among Korea, China and Japan Session Chair : Atsushi Tsukamoto |
Tue, June 25 10:15AM CME, IACET, RN
|
Developing and Maintaining Sponsor/CRO Partnership Regulatory Submissions Processes: Challenges and Successes Session Chair : Bill Leslie |
Tue, June 25 10:15AM CME, IACET, RN
|
Measuring the Impact of Subject Dual Enrollment on Study Data Validity and a Web-based Tool to Avoid Simultaneous Participation in Multiple Concurrent Clinical Trials Session Chair : Darran Boyer |
Tue, June 25 10:15AM CME, IACET, RN
|
Statistical Considerations When Developing Antibacterial Treatments Session Chair : Rima Izem |
Tue, June 25 10:15AM CME, IACET, RN
|
Strategies for the Development and Registration of Antibody Drug Conjugates Session Chair : Sarah C. Pope Miksinski |
Tue, June 25 10:15AM ACPE, CME, IACET, RN
|
EU Update: PROTECT and EnCePP Session Chair : Stella C.F. Blackburn |
Tue, June 25 10:15AM CME, IACET, RN
|
Achieving Innovative Technology Results Session Chair : James O'Keefe |
Tue, June 25 10:15AM CME, IACET, RN
|
Circulating Tumor Cells (CTCs) as a Biomarker Approach in Oncology Session Chair : Kenneth J. Pennline |
Tue, June 25 10:15AM
|
Drug Development for Commercial Success Session Chair : Michele L. Sharp |
Tue, June 25 1:45PM CME, IACET, RN
|
Enrollment Analytics: Moving Beyond the Funnel Session Chair : Paul Ivsin |
Tue, June 25 1:45PM CME, IACET, RN
|
The New European Pharmacovigilance Legislation: Guiding Medical Writers Through the Risks and Benefits Session Chair : Julia Cooper |
Tue, June 25 1:45PM IACET
|
Regulatory, Clinical, and Quality Challenges in Contracting and Due Diligence: The Forgotten Keys to Biopharma Transactions Session Chair : Michael A. Swit |
Tue, June 25 1:45PM ACPE, IACET
|
FDA Collaborations Broaden the Reach of Health Care Messages to Effectively Communicate with the Public Session Chair : Anna M Fine |
Tue, June 25 1:45PM ACPE, CME, IACET, RN
|
Co-development of Targeted Therapies and Companion Diagnostics: Identifying Regulatory Strategies to Overcome Challenges Session Chair : Janet Jenkins-Showalter |
Tue, June 25 1:45PM CME, IACET, RN
|
Is There a Recipe for Successful Implementation of Registries for Rare Diseases? Session Chair : Martine Zimmermann |
Tue, June 25 1:45PM ACPE, CME, IACET, RN
|
Changing View of Electronic Data Capture (EDC) and Implications for Data Quality Session Chair : Laurie S. Callen |
Tue, June 25 1:45PM CME, IACET, RN
|
Periodic Reporting in Drug Safety: From Safety Updates to Continuous Signal Monitoring and Benefit-risk Evaluations Session Chair : Reingart Bordel |
Tue, June 25 1:45PM CME, IACET, RN
|
US and EU Regulatory Update of Clinical Trial Disclosure Session Chair : Barbara Godlew |
Tue, June 25 1:45PM CME, IACET, RN
|
Electronic Submissions in PDUFA V Session Chair : Nancy D. Smith |
Tue, June 25 1:45PM CME, IACET, RN
|
Implementing an Internationally Acceptable Framework for the Benefit-risk Assessment of Medicines: How Close Are We to This? Session Chair : Stuart Walker |
Tue, June 25 1:45PM CME, IACET, RN
|
First-in-Human Studies: How Much Complexity Is Too Much? Session Chair : Royce A. Morrison |
Tue, June 25 1:45PM CME, IACET, RN
|
Learning to Share-Sharing To Learn: How an Industry Learns to Honor Its Volunteers Session Chair : Matt Gross |
Tue, June 25 1:45PM
|
Product Communications in the Preapproval Phase Session Chair : Mark Gaydos |
Tue, June 25 4:00PM CME, IACET, RN
|
Approaches to Risk-based Monitoring Session Chair : Jeffrey S. Handen |
Tue, June 25 4:00PM CME, IACET, RN
|
Evaluating Sites for Optimum Site Selection and Performance Session Chair : Scott R Martin |
Tue, June 25 4:00PM CME, IACET, PMI, RN
|
GCPs in Emerging Countries Session Chair : Fred Feldstein |
Tue, June 25 4:00PM CME, IACET, RN
|
Strategic Planning of the Global Program to Facilitate Regulatory Approval and Market Access Session Chair : Libbie Mansell |
Tue, June 25 4:00PM CME, IACET, RN
|
Optimizing the Transition from Preclinical to Clinical Research Session Chair : Stella Stergiopoulos |
Tue, June 25 4:00PM CME, IACET, RN
|
Diagnostic Biomarker Verification and Validation: A Cost-efficient, Speed to Market Adaptive Design Clinical Trial Model Session Chair : Alan J. Touch |
Tue, June 25 4:00PM CME, IACET, RN
|
Utilizing Electronic Medical Records as an Innovative Methodology for Evaluating Therapeutic Effectiveness Session Chair : Ryan Gifford |
Tue, June 25 4:00PM ACPE, CME, IACET, RN
|
Lessons Learned from the EMA-FDA Quality by Design (QbD) Pilot Session Chair : Evdokia Korakianiti |
Tue, June 25 4:00PM IACET
|
Analysis Data Standards: Developing, Applying, Submitting and Reviewing Session Chair : Stephen E. Wilson |
Tue, June 25 4:00PM CME, IACET, RN
|
So You Want to Foster Innovation: A Neuroscience Primer on How Creative Ideas Arise from the Brain Session Chair : C. Latham Mitchell |
Tue, June 25 4:00PM CME, IACET, RN
|
Real-world Electronic Health Records Data and Informatics Technology in Drug Development and Life Cycle Management Session Chair : Mitra Rocca |
Tue, June 25 4:00PM ACPE, CME, IACET, RN
|
Risk Management in the US, EU and Japan: The Challenges of Diversity Session Chair : Nancy A Dreyer |
Tue, June 25 4:00PM CME, IACET, RN
|
Bringing the Views of “Payer Regulators” into Product Development to Align Label Outcomes and Safety with Patient Access Session Chair : Charles A. Stevens |
Tue, June 25 4:00PM CME, IACET, RN
|
Labeling and Patient Medical Information (PMI) Session Chair : Lynette Hopkinson |
Tue, June 25 4:00PM ACPE, CME, IACET, RN
|
The Evolving Clinical Trial Disclosure Global Landscape Session Chair : Sarah Doyle Larson |
Tue, June 25 4:00PM CME, IACET, RN
|
Investigator Budgets Impact on Patient Enrollment and Retention: How to Improve Sponsor/CRO/Site Processes to Increase Productivity Session Chair : Daniel M Ulrey |
Tue, June 25 4:00PM CME, IACET, RN
|
Four Ways to Accelerate Clinical Portfolio Strategy Session Chair : Larissa Comis-Tis |
Tue, June 25 4:00PM
|
Clinical Trial Design for Optimal Patient Recruitment and Retention Session Chair : William W. Gwinn |
Wed, June 26 8:00AM CME, IACET, RN
|
Tethering the Channels of Scientific and Medical Content Session Chair : J. Lynn Bass |
Wed, June 26 8:00AM CME, IACET, RN
|
Using Legislation to Advance Regulatory Science: "I'm Just a Bill..." Session Chair : Karen E. Jaffe |
Wed, June 26 8:00AM ACPE, CME, IACET, RN
|
How Will Risk-adapted Clinical Trials Be Inspected? Session Chair : John Poland |
Wed, June 26 8:00AM CME, IACET, RN
|
Cost Management for Global Drug Development Projects Session Chair : Mark A. Kryah |
Wed, June 26 8:00AM CME, IACET, PMI, RN
|
Stop Moving the Goalposts: A Life Cycle Approach to Risk-based Quality Management in Clinical Development Session Chair : Barbara Leishman |
Wed, June 26 8:00AM CME, IACET, RN
|
Unique Nonprofit-Industry Partnerships to Develop and Disseminate Technology Session Chair : Badri Rengarajan |
Wed, June 26 8:00AM IACET
|
Molecular Imaging: Utilizing It as an Effective Drug Development Tool Session Chair : Todd E. Peterson |
Wed, June 26 8:00AM ACPE, CME, IACET, RN
|
How to Convert a New Device (PMA) into an Old (510(k)) Device: The De Novo 510(k) Session Chair : Michael A. Swit |
Wed, June 26 8:00AM ACPE, CME, IACET, RN
|
The Environment for Health Care Decision-making: Collecting, Using and Understanding Comparative Effectiveness Research Session Chair : Kimberly Westrich |
Wed, June 26 8:00AM ACPE, CME, IACET, RN
|
Quantitative Benefit-risk in the Current Regulatory Environment and the Implications for Clinical Statisticians Session Chair : Susan P. Duke |
Wed, June 26 8:00AM CME, IACET, RN
|
How Economic and Technological Change Can Affect Professional Expectations: Case Studies in Succeeding in the Midst of Change Session Chair : Elizabeth Lincoln |
Wed, June 26 8:00AM CME, IACET, RN
|
Enhancing Regulatory Science and Expediting Drug Development: eClinical and eHealth Tools Session Chair : Ron Fitzmartin |
Wed, June 26 8:00AM ACPE, CME, IACET, RN
|
Models for Genomic Research Success: Empowering Patient-Researcher Relationships and the Emerging Role of Crowd Sourcing in Rare Disease Research Session Chair : Cheng-Ho Lin |
Wed, June 26 8:00AM CME, IACET, RN
|
Molecular Predictors of Drug-induced Harm: From Clinical Development to Postmarketing Surveillance Session Chair : Niklas Noren |
Wed, June 26 8:00AM ACPE, CME, IACET, RN
|
Pharmacovigilance Update for Japan, Developing Asia and Latin America Session Chair : Stewart Geary |
Wed, June 26 8:00AM CME, IACET, RN
|
Regulatory Operations: Types and Industry Trends of Outsourcing the Life Cycle Management of Your Electronic Submissions Session Chair : Janel Demeter |
Wed, June 26 8:00AM IACET
|
FDASIA: Impact of New Legislative Provisions on Innovative Drug Development Session Chair : Janet Jenkins-Showalter |
Wed, June 26 8:00AM CME, IACET, RN
|
Bringing SPIRIT into Protocols, Structuring Content and Expanding This Work to Noninterventional Postmarketing Protocols Session Chair : Helle Gawrylewski |
Wed, June 26 8:00AM CME, IACET, RN
|
Globalization of Medical Communications/Medical Science Liaisons: A Comparison of Guidance and Practice Differences Session Chair : Thomas M. Gesell |
Wed, June 26 10:15AM CME, IACET, RN
|
Innovative Strategies for Evolving Sponsor, CRO and Site Alliances Session Chair : Mick O'Quigley |
Wed, June 26 10:15AM IACET, PMI
|
Pharmacometrics: Implications and Impact in Preclinical to Early Phase Clinical Development Session Chair : Royce A. Morrison |
Wed, June 26 10:15AM CME, IACET, RN
|
Recent Corporate Integrity Agreements: Impact on Industry-sponsored Publications and Medical Communications Activities Session Chair : Monica A. Kwarcinski |
Wed, June 26 1:45PM CME, IACET, RN
|
FDA/EMA/WHO Collaboration and Cooperation on Good Clinical Practice (GCP), Bioequivalence (BE) and Pharmacovigilance (PV) Inspections Session Chair : Cynthia Kleppinger |
Wed, June 26 1:45PM CME, IACET, RN
|
Using Competence Models to Drive High Quality Drug Project Management Session Chair : Peter Harpum |
Wed, June 26 1:45PM CME, IACET, PMI, RN
|
Towards an Effective Virtual R&D Team for Faster Accessing of the East Asian Market Session Chair : Deborah Chee |
Wed, June 26 1:45PM CME, IACET, PMI, RN
|
Developing Effective Policy Strategies for Coverage and Reimbursement of Companion Diagnostics Session Chair : Paul Sheives |
Wed, June 26 1:45PM ACPE, CME, IACET, RN
|
The 2012 US Payer Landscape: Results from a Survey of Medical and Pharmacy Directors on Comparative Effectiveness Research Session Chair : Richard Alan Brook |
Wed, June 26 1:45PM ACPE, CME, IACET, RN
|
Clinical Trial Simulations and Modeling Session Chair : David A. Amato |
Wed, June 26 1:45PM CME, IACET, RN
|
Cloud Technology for Decision Makers: What’s Real and How to Validate It Session Chair : Teri E. Stokes |
Wed, June 26 1:45PM CME, IACET, RN
|
Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market Session Chair : Cecil J. Nick |
Wed, June 26 1:45PM CME, IACET, RN
|
Canadian Approaches to Regulatory Modernization and International Engagement Session Chair : Agnes V. Klein |
Wed, June 26 1:45PM CME, IACET, RN
|
FDASIA Patient Provisions: One Year Later Session Chair : James E. Valentine |
Wed, June 26 1:45PM CME, IACET, RN
|
eSubmission Outsourcing and Mergers and Acquisitions: Now This Is an Intriguing Equation Session Chair : Daniel F. Orfe |
Wed, June 26 1:45PM IACET
|
Coalition for Accelerating Standards and Therapies (CFAST): The Ultimate Drug Development Drivers Session Chair : Rebecca D. Kush |
Wed, June 26 1:45PM ACPE, CME, IACET, RN
|
Clinical Outcome Assessment for Clinical Trials: PROs, ClinROs, and ObsROs Session Chair : Melvyn Greberman |
Wed, June 26 1:45PM ACPE, CME, IACET, RN
|
TransCelerate’s Collaborative Approach to Risk-based Monitoring: The Methodology Session Chair : Craig A Wozniak |
Wed, June 26 1:45PM CME, IACET, RN
|
Meeting the Challenges of Health Care Disparities and Clinical Trial Requirements in the Global Environment Session Chair : Florence Houn |
Wed, June 26 4:00PM ACPE, CME, IACET, RN
|
Pharmaceutical Project Management: What's Really Important and How Can We Do Better? Session Chair : John Z. Sun |
Wed, June 26 4:00PM IACET, PMI
|
Noninferiority Trials in Drug Development: Clinical, Statistical and Regulatory Perspectives Session Chair : Surya P. Chitra |
Wed, June 26 4:00PM CME, IACET, RN
|
Ensuring Patient-centered Care: Partnering with Patient Advocacy Session Chair : Vicki Breitbart |
Wed, June 26 4:00PM ACPE, CME, IACET, RN
|
Implementation of Quality by Design: Progress, Challenges and Opportunities - FDA Perspective
Session Chair : Christine M. V. Moore |
Wed, June 26 4:00PM ACPE, CME, IACET, RN
|
Data Standards Strategy Session Chair : Stephen E. Wilson |
Wed, June 26 4:00PM CME, IACET, PMI, RN
|
Challenges for Stable Supply of Drugs and International Cooperation Session Chair : Nobumasa Nakashima |
Wed, June 26 4:00PM ACPE, CME, IACET, RN
|
Herbal-induced Liver Injury (HILI): How That May Impact Rx Benefit-Risk
Session Chair : Pradip K. Paul |
Wed, June 26 4:00PM CME, IACET, RN
|
Developing a Patient Aid to Make Information about Treatment Benefits, Harms and Uncertainties Meaningful to Individual Patients and Enhance Their Decisions Session Chair : Robyn R. Lim |
Wed, June 26 4:00PM ACPE, CME, IACET, RN
|
Global Pediatric Development: Next Steps Session Chair : Chin Koerner |
Wed, June 26 4:00PM CME, IACET, RN
|
Electronic Regulatory Submission (ERS) Development and the Impact on the Sponsor’s Organization: Retooling R&D for ERS Session Chair : Peter M. Lassoff |
Wed, June 26 4:00PM CME, IACET, RN
|
Current Regulatory Landscape Impacting Medical and Scientific Communications Session Chair : Mary K. Sendi |
Wed, June 26 4:00PM ACPE, CME, IACET, RN
|
Collaborative Approach for Site Qualification and Training Efficiencies Session Chair : Megan Schaeffer |
Wed, June 26 4:00PM CME, IACET, RN
|
Key Learnings from the Approval and Launch of a 505(b)(2) Product from a Medical Communications Perspective Session Chair : Tamar S. Yarkoni |
Thu, June 27 9:00AM CME, IACET, RN
|
Parents as Partners: Engaging Caregivers for Pediatric Trials Session Chair : Donald Sickler |
Thu, June 27 9:00AM CME, IACET, RN
|
Orphan Drug Development Strategy by Big and Medium/Small Pharmaceutical Industries Session Chair : Noriaki Murao |
Thu, June 27 9:00AM ACPE, CME, IACET, RN
|
Patient-centered Predictive Modeling and Its Role in Creating a Learning Health System Session Chair : Matthew D. Rousculp |
Thu, June 27 9:00AM ACPE, CME, IACET, RN
|
Postapproval Change Management: Challenges and Opportunities Session Chair : Christine M. V. Moore |
Thu, June 27 9:00AM CME, IACET, RN
|
Some Innovative Approaches to Handling Missing Data Problems in Clinical Trials Session Chair : Peiling Yang |
Thu, June 27 9:00AM CME, IACET, RN
|
eDM From Three Sponsors Session Chair : Bhanu Bahl |
Thu, June 27 9:00AM IACET
|
The Not So Rare Challenge that Faces Rare Disease Development: Demonstrate Value Session Chair : Charles A. Stevens |
Thu, June 27 9:00AM CME, IACET, RN
|
Changing Landscape of IT in the Pharmaceutical Industry Session Chair : Pamela Campbell |
Thu, June 27 9:00AM CME, IACET, RN
|
Tracking Misuse and Abuse of Marketed Products: Is Pharma Doing All that It Can? Session Chair : Mitch Miller |
Thu, June 27 9:00AM ACPE, CME, IACET, RN
|
Insights into China: Practical Tips for Writing Publication and Regulatory Documents Session Chair : Julie A. Ely |
Thu, June 27 10:45AM CME, IACET, RN
|
CRA’s Knowledge and Adaptability Required to Monitor Informed Consent Process in an Evolving Regulatory Environment Session Chair : Maria del Pilar Torres |
Thu, June 27 10:45AM CME, IACET, RN
|
The Importance of Country Selection in Clinical Study Design Session Chair : Joan M Meyer |
Thu, June 27 10:45AM CME, IACET, RN
|
Transforming Relationships to Adapt to Evolving Organizational Strategic Goals Session Chair : Alison Holland |
Thu, June 27 10:45AM CME, IACET, PMI, RN
|
Bayesian Methods in Medical Product Development and Comparative Effectiveness Session Chair : David Ohlssen |
Thu, June 27 10:45AM ACPE, CME, IACET, RN
|
Emerging Electronic Tools in Cardiovascular Outcomes Studies Session Chair : Jonathan Plehn |
Thu, June 27 10:45AM CME, IACET, RN
|
Implementing a Paperless Trial for Phase 3: A Biotech’s Lessons Learned Session Chair : Mary R. Flack |
Thu, June 27 10:45AM CME, IACET, RN
|
What's the Point? Can Point of Care Devices Enhance Clinical Trials? Session Chair : Erin Iturriaga |
Thu, June 27 10:45AM CME, IACET, RN
|
Off-target Blood Pressure Changes and Evaluation in Drug Development: Safety, Clinical and Regulatory Considerations Session Chair : Jeffrey Heilbraun |
Thu, June 27 10:45AM ACPE, CME, IACET, RN
|
Certificate of Pharmaceutical Product (CPPs): How Can the Process for Obtaining from and Submitting to Health Authorities Be Made More Efficient? Moving from Ribbons and Wax to Electronic Solutions Session Chair : Fraser McKillop Stodart |
Thu, June 27 10:45AM CME, IACET, RN
|